Spectral Med Financials

Spectral Med Stock Summary

Spectral Med competes with BioAffinity Technologies,, BioMark Diagnostics, Mainz Biomed, Standard Biotools, and Guardant Health. Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 31 people.

Spectral Med Key Financial Ratios

There are many critical financial ratios that Spectral Med's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Spectral Med reports annually and quarterly.

Spectral Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Spectral Med's current stock value. Our valuation model uses many indicators to compare Spectral Med value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spectral Med competition to find correlations between indicators driving Spectral Med's intrinsic value. More Info.Spectral Med is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Spectral Med's earnings, one of the primary drivers of an investment's value.

Spectral Med Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Spectral Med help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Spectral Med. We use our internally-developed statistical techniques to arrive at the intrinsic value of Spectral Med based on widely used predictive technical indicators. In general, we focus on analyzing Spectral Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Spectral Med's daily price indicators and compare them against related drivers.

When running Spectral Med's price analysis, check to measure Spectral Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spectral Med is operating at the current time. Most of Spectral Med's value examination focuses on studying past and present price action to predict the probability of Spectral Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spectral Med's price. Additionally, you may evaluate how the addition of Spectral Med to your portfolios can decrease your overall portfolio volatility.